Overall, progression-free survival worse for oligometastatic NSCLC patients with versus without detectable ctDNA before radiotherapy

PLCOm2012 models have higher sensitivity than USPSTF criteria, with no difference by Indigenous classification

Model relies only on age, smoking duration, and pack-years

Early menarche, early menopause, shortened reproductive life span linked to increased risk, especially for NSCLC

Intensity-modulated radiation therapy spares more normal tissue than 3D-conformal radiotherapy

Removal of race correction was tied to a significant reduction in the estimation of lung function for African Americans

Meta-analysis only shows a 110-day survival benefit for colorectal cancer screening with sigmoidoscopy

Single-site cancer screening could save an additional 3.2 to 5.1 million life-years with perfect adherence

First-line atezolizumab monotherapy is associated with improved overall survival compared with single-agent chemotherapy

Median time to treatment was 39 days for ACCELERATE cohort versus 62 days for reference cohort using standard tissue genotyping